Quality Management Optimizing HEDIS & STARSMedicare AdvantageMarch 14, 2025

Glycemic Status Assessment for Patients with Diabetes (GSD) 2025

HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.

HEDIS measure

The Glycemic Status Assessment for Patients with Diabetes (GSD) measure looks at the percentage of patients 18 to 75 years old with diabetes (types 1 and 2) whose most recent glycemic status (hemoglobin A1c HbA1c or glucose management indicator [GMI]) was at the following levels during the measurement year:

  • Glycemic status < 8%
  • Glycemic status ≤ 9%

Note: Groups are measured on only one of the two numerators (< 8 or ≤ 9). Check your measurement period handbook for your applicable numerator. Also, note that the standard HEDIS metric of non-compliance (values > 9.0) has been inverted for consistency (higher rates = better performance).

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Blue Cross Blue Shield Healthcare Plan of Georgia, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-079568-25-CPN79281

ATTACHMENTS: Glycemic Status Assessment for Patients with Diabetes (GSD) 2025 (pdf - 0.07mb)